Vertex Pharmaceuticals Incorporated (VRTX)

Market Closed

10 Aug, 20:00

NASDAQ (NGS)

523. 91

+27.84

+5.6121%

121.5B Market Cap

30.83 P/E Ratio

- Div Yield

2.67M Volume

14.94 Eps

$ 496.07

Previous Close

Investors:

Analysts:

Day Range

519.82 546.17

Year Range

362.5 546.17

Want to track VRTX and more in your Portfolio? 🎯

Vertex Pharmaceuticals Incorporated Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
AAI ABN AMRO Investment Solutions ABN AMRO Investment Solutions	84,631	$37.78M	$40.38M	$2.6M	6.88%
Landon Marsh Scott Marsh Financial LLC	1,504	$669,582	$717,558.42	$47,976.42	7.17%
GWM Gibbs Wealth Management Gibbs Wealth Management	5,647	$2.52M	$2.69M	$173,232.68	6.87%
Provenance Wealth Advisors LLC Provenance Wealth Advisors LLC	10	$4,967	$4,771	-$196	-3.95%
Michael Behner Nautilus Advisors LLC	777	$363,256.57	$370,706.71	$7,450.14	2.05%
TGI Torrey Growth & Income Advisors Torrey Growth & Income Advisors	4,710	$1.84M	$2.25M	$402,516.65	21.82%
United Financial Planning Group LLC United Financial Planning Group LLC	14	$6,258.55	$6,787.62	$529.07	8.45%
BML Berman McAleer LLC Berman McAleer LLC	574	$226,591.34	$273,855.41	$47,264.07	20.86%
Jon Borer Capitolis Liquid Global Markets LLC	16,806	$7.59M	$8.02M	$426,193.69	5.61%
Jesper Lorenzen Danica Pension Livsforsikringsaktieselskab	27,829	$12.51M	$13.81M	$1.3M	10.4%
WMA William Mack & Associates Inc. William Mack & Associates Inc.	630	$253,700.63	$300,573.01	$46,872.38	18.48%